Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review

被引：0
|
作者：
Matteo Bassetti
Maddalena Peghin
Antonio Vena
机构：
[1] Azienda Sanitaria Universitaria Integrata,Infectious Diseases Clinic, Department of Medicine University of Udine
来源：
Infectious Diseases and Therapy | 2018年 / 7卷
关键词：
Biomarkers; Galactomannan; Invasive aspergillosis; Liver cirrhosis; Non-neutropenic patients;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Invasive aspergillosis (IA) is a serious opportunistic infection, which has increasingly been recognized as an emerging disease of non-neutropenic patients. In this group of patients, the diagnosis of IA can be challenging owing to the lack of specificity of symptoms, the difficulty in discriminating colonization from infection, and the lower sensitivity of microbiological and radiological tests compared with immunocompromised patients. The aim of this article is to present to clinicians a critical review on the management of IA in non-neutropenic patients.
引用
收藏
页码：17 / 27
页数：10
相关论文
共 50 条
  • [31] Performance of an Aspergillus fumigatus real-time PCR assay using serum for the diagnosis of invasive aspergillosis in neutropenic and non-neutropenic patients
    Imbert, S.
    Gauthier, L.
    Palous, M.
    Joly, I.
    Gay, F.
    Brun, S.
    Brossas, J.
    Mazier, D.
    Datry, A.
    Fekkar, A.
    MYCOSES, 2015, 58 : 44 - 44
  • [32] Diagnostic value of galactomannan in serum and bronchoalveolar lavage fl uid for invasive pulmonary aspergillosis in non-neutropenic patients
    Wu, Ziwei
    Wang, Ling
    Tan, Li
    Wu, Jiali
    Chen, Zhiyang
    Hu, Min
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2021, 99 (04)
  • [33] Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients
    M Ruhnke
    J Paiva
    W Meersseman
    J Pachl
    I Grigoras
    G Sganga
    F Menichetti
    P Montravers
    G Auzinger
    G Dimopoulos
    M Borges Sá
    P Miller
    T Marček
    M Kantecki
    Critical Care, 15 (Suppl 1):
  • [34] Fatal invasive aspergillosis in a non-neutropenic cystic fibrosis patient post liver transplantation.
    Powell, A
    Thomas, H
    Hewer, SL
    Dyer, J
    Wong, J
    Henderson, J
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 68 - 69
  • [35] Efficacy of caspofungin in neutropenic and non-neutropenic patients
    Glasmacher, A
    Comely, O
    Orlopp, K
    Egerer, G
    Blaschke, S
    Siemann, M
    Reuter, S
    Florek, M
    Kathofer, S
    Schnitzler, R
    Reinel, H
    Just-Nuebling, G
    BONE MARROW TRANSPLANTATION, 2003, 31 : S33 - S34
  • [36] INVASIVE ASPERGILLOSIS IN NEUTROPENIC PATIENTS
    COMETTA, A
    GLAUSER, MP
    FRANCIOLI, P
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, : 51 - 51
  • [37] Itraconazole IV solution in the treatment of candidemia in non-neutropenic patients
    O Tuil
    Y Cohen
    Critical Care, 7 (Suppl 2):
  • [38] Management of invasive candidiasis in non-neutropenic patient
    Cardozo, Celia
    Mensa, Jose
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2015, 28 : 34 - 37
  • [39] The uncommon meets the common: Invasive Aspergillosis and tuberculosis co-infection in non-neutropenic patients- arare association
    Akshatha, R.
    Bohra, Gopal Krishna
    Shankar, Durga
    Kumar, Deepak
    Midha, Naresh Kumar
    Jain, Vidhi
    Sharma, Shivang
    Santhanam, N.
    Garg, Mahendra Kumar
    Singh, Kuldeep
    Chauhan, Nishant Kumar
    Sharma, Ankur
    MEDICAL MYCOLOGY, 2022, 60 (SUPP 1) : 94 - 94
  • [40] Development of Aspergillosis in a cohort of non-neutropenic, non-transplant patients colonised by Aspergillus spp
    José Barberán
    Francisco-Javier García-Pérez
    Victoria Villena
    Alberto Fernández-Villar
    Eduardo Malmierca
    Cristina Salas
    María-José Giménez
    Juan-José Granizo
    Lorenzo Aguilar
    BMC Infectious Diseases, 17
12345